GWM
HURA

Greenline Wealth Management’s TuHURA Biosciences HURA Stock Holding History

Greenline Wealth Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.2K Sell
18,464
-18,463
-50% -$43K 0.04% 131
2026
Q1 		$66.1K Buy
+36,927
New +$45.3K 0.08% 94

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Greenline Wealth Management's HURA Position: Q2 2026 in Review

Greenline Wealth Management reduced its TuHURA Biosciences (HURA) stake by 50% in Q2 2026, selling an estimated $43K and leaving 18,464 shares worth $43.2K. The position accounts for 0.04% of the portfolio, ranked #131.

Greenline Wealth Management first reported a position in HURA in Q1 2026 and has held it in 2 quarters since. The position peaked at $66.1K in Q1 2026. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Greenline Wealth Management held 18,464 shares of TuHURA Biosciences worth $43.2K as of Q2 2026.
  • Greenline Wealth Management sold 18,463 TuHURA Biosciences shares in Q2 2026, an estimated $43K.
  • TuHURA Biosciences made up 0.04% of Greenline Wealth Management's portfolio in Q2 2026, its #131 holding.
  • Greenline Wealth Management first reported a position in TuHURA Biosciences in Q1 2026 and has held it in 2 quarters since.
  • Greenline Wealth Management's TuHURA Biosciences position peaked at $66.1K in Q1 2026.
  • 90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Greenline Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.